PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
InfuSystem Holdings Inc. (INFU)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US45685K1025

CUSIP

45685K102

Sector

Healthcare

IPO Date

Dec 27, 2007

Highlights

Market Cap

$191.16M

EPS (TTM)

$0.07

PE Ratio

128.43

Total Revenue (TTM)

$132.78M

Gross Profit (TTM)

$68.65M

EBITDA (TTM)

$17.75M

Year Range

$5.74 - $10.99

Target Price

$14.13

Short %

0.94%

Short Ratio

3.56

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
INFU vs. PESI INFU vs. QRHC INFU vs. NOAH INFU vs. VTI
Popular comparisons:
INFU vs. PESI INFU vs. QRHC INFU vs. NOAH INFU vs. VTI

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in InfuSystem Holdings Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%40.00%50.00%JuneJulyAugustSeptemberOctoberNovember
38.52%
11.03%
INFU (InfuSystem Holdings Inc.)
Benchmark (^GSPC)

Returns By Period

InfuSystem Holdings Inc. had a return of -14.71% year-to-date (YTD) and -3.23% in the last 12 months. Over the past 10 years, InfuSystem Holdings Inc. had an annualized return of 12.51%, outperforming the S&P 500 benchmark which had an annualized return of 11.10%.


INFU

YTD

-14.71%

1M

28.06%

6M

38.52%

1Y

-3.23%

5Y (annualized)

3.16%

10Y (annualized)

12.51%

^GSPC (Benchmark)

YTD

23.56%

1M

0.49%

6M

11.03%

1Y

30.56%

5Y (annualized)

13.70%

10Y (annualized)

11.10%

Monthly Returns

The table below presents the monthly returns of INFU, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-12.43%0.22%-7.35%-12.37%-4.93%-4.34%1.02%-3.62%0.75%-7.61%-14.71%
202315.44%-6.29%-17.47%20.90%-6.62%10.06%7.17%-0.39%-6.23%-0.62%4.70%5.08%21.43%
2022-11.33%-23.91%-14.71%-19.08%21.94%-0.41%1.45%-21.08%-9.34%9.16%12.45%1.17%-49.03%
2021-6.18%-3.18%19.34%11.10%-18.21%12.38%-12.22%-21.92%-8.56%27.63%-0.48%2.90%-9.32%
20200.59%23.54%-19.91%41.93%-3.65%-0.60%5.81%19.16%-11.89%-3.90%29.87%17.38%120.16%
20199.88%6.88%24.01%-14.17%13.95%-12.24%3.26%12.16%6.22%31.00%20.63%2.03%147.97%
20180.00%-2.17%28.89%-4.94%17.89%9.23%-14.08%9.84%-2.99%-5.23%11.36%0.29%49.57%
2017-9.80%-4.35%4.55%-10.87%-26.83%16.67%5.71%2.70%7.89%-2.44%17.50%-2.13%-9.80%
2016-7.28%14.29%10.00%2.27%-15.83%-14.19%13.46%-5.42%-0.36%-8.27%-31.37%45.71%-15.56%
2015-12.38%-4.35%2.65%13.28%3.26%0.63%-1.57%-10.83%-1.43%-1.45%7.72%3.07%-4.13%
201439.25%-11.41%5.15%1.59%-0.71%-5.36%4.91%0.72%12.14%25.48%-29.95%14.13%47.20%
20134.00%3.85%7.56%-17.93%9.79%-5.10%0.67%-8.67%-6.57%17.15%26.71%12.63%42.67%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of INFU is 39, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of INFU is 3939
Combined Rank
The Sharpe Ratio Rank of INFU is 3939
Sharpe Ratio Rank
The Sortino Ratio Rank of INFU is 3838
Sortino Ratio Rank
The Omega Ratio Rank of INFU is 3636
Omega Ratio Rank
The Calmar Ratio Rank of INFU is 4040
Calmar Ratio Rank
The Martin Ratio Rank of INFU is 4141
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for InfuSystem Holdings Inc. (INFU) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for INFU, currently valued at -0.04, compared to the broader market-4.00-2.000.002.004.00-0.042.51
The chart of Sortino ratio for INFU, currently valued at 0.35, compared to the broader market-4.00-2.000.002.004.000.353.36
The chart of Omega ratio for INFU, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.47
The chart of Calmar ratio for INFU, currently valued at -0.03, compared to the broader market0.002.004.006.00-0.033.62
The chart of Martin ratio for INFU, currently valued at -0.06, compared to the broader market-10.000.0010.0020.0030.00-0.0616.12
INFU
^GSPC

The current InfuSystem Holdings Inc. Sharpe ratio is -0.04. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of InfuSystem Holdings Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.

Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
-0.04
2.51
INFU (InfuSystem Holdings Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


InfuSystem Holdings Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-60.78%
-1.80%
INFU (InfuSystem Holdings Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the InfuSystem Holdings Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the InfuSystem Holdings Inc. was 78.33%, occurring on Oct 17, 2011. Recovery took 741 trading sessions.

The current InfuSystem Holdings Inc. drawdown is 60.78%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-78.33%Feb 4, 2008633Oct 17, 2011741Oct 27, 20141374
-74.69%May 4, 2021821Aug 7, 2024
-69.7%Oct 28, 2014643May 18, 2017455Mar 14, 20191098
-51.49%Feb 21, 202019Mar 18, 202021Apr 17, 202040
-19.84%Apr 22, 202017May 14, 202059Aug 7, 202076

Volatility

Volatility Chart

The current InfuSystem Holdings Inc. volatility is 23.23%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
23.23%
4.06%
INFU (InfuSystem Holdings Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of InfuSystem Holdings Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of InfuSystem Holdings Inc. compared to its peers in the Medical Instruments & Supplies industry.


PE Ratio
50.0100.0150.0200.0128.4
The chart displays the price to earnings (P/E) ratio for INFU in comparison to other companies of the Medical Instruments & Supplies industry. Currently, INFU has a PE value of 128.4. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.
PEG Ratio
0.05.010.015.020.00.0
The chart displays the price to earnings to growth (PEG) ratio for INFU in comparison to other companies of the Medical Instruments & Supplies industry. Currently, INFU has a PEG value of 0.0. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for InfuSystem Holdings Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items